1.30 (-%)
As of Nov 29, 2024
Source:
Atossa Therapeutics, Inc is a clinical-stage biopharmaceutical company developing proprietary innovative medicines in areas of significant unmet medical need in oncology, with a current focus on breast cancer and other breast conditions.
Country | United States |
Headquarters | seattle, washington |
Phone Number | 206.588.0256 |
Industry | manufacturing |
CEO | Steven C. Quay, M.D., Ph.D. |
Website | www.atossatherapeutics.com |